S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
ETFs
UK
LSE
Ls 2x Salesforc (CRME)
Ls 2x Salesforc (CRME) News

CRME

Ls 2x Salesforc (CRME)

Ls 2x Salesforc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:CRME

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
04/24/2023	9:47AM	UK Regulatory	Leverage Shares PLC Issuer Call Redemption Confirmation	LSE:CRME	Ls 2x Salesforc
12/21/2009	4:05PM	PR Newswire (US)	Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase Plans	LSE:CRME
12/17/2009	5:00PM	PR Newswire (US)	Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study	LSE:CRME
11/09/2009	7:40AM	PR Newswire (US)	Cardiome Reports Third Quarter Results	LSE:CRME
11/06/2009	5:00PM	PR Newswire (US)	Cardiome to Release Third Quarter Results	LSE:CRME
11/02/2009	1:35PM	PR Newswire (US)	Cardiome To Present At Oppenheimer Healthcare Conference	LSE:CRME
10/28/2009	3:58PM	PR Newswire (US)	Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial	LSE:CRME
10/16/2009	7:54PM	PR Newswire (US)	Cardiome Pharma Corp. Announces Final Results of Tender Offer	LSE:CRME
10/14/2009	5:00AM	PR Newswire (US)	Cardiome Pharma Corp. Announces Preliminary Results of Tender Offer	LSE:CRME
09/01/2009	1:57PM	PR Newswire (US)	Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer	LSE:CRME
08/28/2009	12:30PM	PR Newswire (US)	Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of	LSE:CRME
08/25/2009	4:11PM	PR Newswire (US)	Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares	LSE:CRME
08/11/2009	6:45AM	PR Newswire (US)	Cardiome Reports Second Quarter Results	LSE:CRME
08/10/2009	6:45PM	PR Newswire (US)	Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement	LSE:CRME
08/10/2009	3:35PM	PR Newswire (US)	Cardiome to Hold Conference Call	LSE:CRME
08/03/2009	4:16PM	PR Newswire (US)	Cardiome Announces Management Transition	LSE:CRME
07/28/2009	10:45AM	PR Newswire (US)	Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.	LSE:CRME
05/19/2009	7:30AM	PR Newswire (US)	Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective	LSE:CRME
05/15/2009	3:05PM	PR Newswire (US)	Cardiome Reports First Quarter Results	LSE:CRME
04/08/2009	5:13PM	PR Newswire (US)	Cardiome to Hold Conference Call	LSE:CRME
11/28/2008	4:31PM	PR Newswire (US)	Cardiome Discloses Chairman And CEO's Involuntary Share Sale	LSE:CRME
11/14/2008	5:40PM	PR Newswire (US)	Cardiome Reports Third Quarter Results	LSE:CRME
10/23/2008	9:40PM	PR Newswire (US)	Cardiome Announces Filing Of Shelf Registration Statement	LSE:CRME
10/09/2008	11:20AM	PR Newswire (US)	Cardiome Provides Regulatory Update	LSE:CRME
08/12/2008	3:05PM	PR Newswire (US)	Cardiome Reports Second Quarter Results	LSE:CRME
08/11/2008	3:30PM	PR Newswire (US)	Cardiome to Release Second Quarter Results and Hold Conference Call	LSE:CRME
08/11/2008	8:18AM	PR Newswire (US)	Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)	LSE:CRME
07/23/2008	1:10PM	PR Newswire (US)	Cardiome Announces Preferred Share Financing	LSE:CRME
07/14/2008	7:25AM	PR Newswire (US)	Cardiome Announces Positive Phase 2b Results For Oral Vernakalant	LSE:CRME
07/13/2008	11:00AM	PR Newswire (US)	Cardiome To Hold Conference Call	LSE:CRME

Showing the most relevant articles for your search:LSE:CRME

1 2 3 4 Next >>

Tonix Pharmaceuticals

Moon Equity (PK)

TheGlobe com (PK)

NioCorp Developments

AMC Entertainment

Northwest Biotherapeutics (QB)

Lightwave Logic

Code Green Apparel (PK)

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions